Could a simple blood protein boost stroke recovery?
NCT ID NCT07365475
First seen Jan 28, 2026
Summary
This Phase 2 trial tests whether giving human albumin directly into the artery supplying the brain, right after a clot is removed, can improve recovery in people with severe stroke. About 306 participants will be randomly assigned to receive either standard clot removal alone or clot removal plus albumin. The goal is to see if albumin helps more patients regain independence three months later.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE FROM LARGE VESSEL OCCLUSION are added.
By submitting, you agree to our Terms of use
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
human albumin (a protein in blood that may protect the brain)
What this could lead to
If it works, this could offer a simple add-on treatment to help more stroke survivors regain independence after clot removal.
What could go wrong
This is a Phase 2 trial, so it is still early. The benefit is uncertain, and there is a small risk of bleeding or allergic reaction from the albumin infusion.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.